US · Healthcare · Medical Care Facilities
EPS came in at 1.72 against a street estimate of 1.63 — a beat of 5.5%.
Analysts rate The Ensign Group Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $220.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.64% |
| Baillie Gifford & Co Limited. | 8.28% |
| Vanguard Portfolio Management, LLC | 5.35% |
| Vanguard Capital Management, LLC | 4.45% |
| FMR Inc | 3.94% |
| Wasatch Advisors LP | 3.91% |
| State Street Corp | 3.54% |
| Geode Capital Management, LLC | 2.90% |
| Document | Date |
|---|---|
| Results announced · Q3 2026 | 2026-07-27 |
| Quarterly report · Q2 2026 | 2026-07-27 |
| Company announcement · Q2 2026 | 2026-06-15 |
| Company announcement · Q2 2026 | 2026-06-10 |
| Shareholder vote results · Q2 2026 | 2026-05-18 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-02 |
| Annual report FY2025 | 2026-02-04 |
Readable in the app.
| Announcement | Date |
|---|---|
| Board approves $60 million increase to stock repurchase program The Ensign Group's Board of Directors approved a $60 million increase to its stock repurchase program on June 12, 2026, expanding total authorized repurchase capacity from $40 million to $10 | 2026-06-15 |
| Board approves $40 million stock repurchase program On May 13, 2026, the company's Board of Directors approved a new $40 million stock repurchase program. This authorization allows the company to buy back its own shares in the open market or | 2026-06-10 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for The Ensign Group Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.